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Abstract 
Background: A vascular disease could be involved in pathophysiology of normal pressure hydrocephalus (INPH). If 
so, there should be an association between INPH and cerebral microbleeds (CMB). This study aims to analyze if CMB 
are associated with INPH.
Methods: In this case-control study we included 14 patients with INPH (mean age 76 years, 60 % female) and 41 
healthy controls (HeCo; mean age 71 years, 60 % female). All were investigated with magnetic resonance imaging 
(MRI) using a T2*-sequence. The MRI exams were reviewed by two neuroradiologists for the presence of CMBs; the 
prevalence of findings of two or more CMBs was compared between INPH group and control group. After investiga-
tion, INPH patients underwent shunt surgery.
Results: Two or more CMB were detected more frequently in the INPH group compared to HeCo (n = 6, 43 % vs. 
n = 4, 10 %; p = 0.01). Among the participants where MRI revealed CMB, the number of CMB was higher among the 
INPH patients than the HeCo (median 8; IQR 2-34 vs. median 1; IQR 1–2; p = 0.005).
Conclusions: This study supports a vascular component to the pathophysiology of INPH.
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Background
Idiopathic normal pressure hydrocephalus is a syndrome 
featuring communicating hydrocephalus in combination 
with a symptom triad of balance- and gait-disturbance, 
cognitive decline and urinary incontinence. In Sweden, 
the prevalence in the 70–79 year age group is 0.2 %, ris-
ing to nearly 6  % in individuals over 80  years [1]. The 
pathophysiology is probably multi-factorial [2]. As INPH 
patients improve with cerebrospinal fluid (CSF) drain-
age, a CSF dynamic disturbance is usually considered 
the main etiological component. In recent years, small 
vessel disease has emerged as an alternative mechanism 
to explain part of the pathophysiological process in that 
vascular risk factors, manifest vascular disease, and white 
matter hyperintensities have all been associated with 
INPH [3].
Cerebral microbleeds are iron deposits in the brain 
that are associated pathologically with hemosiderin-
laden macrophages [4]. Mainly located around small 
vessels, and revealed in iron-sensitive MRI sequences, 
CMB are associated with moderate cognitive decline, 
several causes of dementia and several vascular risk fac-
tors including age, hypertension, lacunar infarctions, 
white matter lesions and diabetes [4–9]. However, the 
association between CMB and INPH has not been stud-
ied. The vascular hypothesis that part of the INPH syn-
drome could be explained by small vessel disease, would 
be strengthened if there is an association between INPH 
and CMB. The aim of this study was to analyze if CMB 
are associated with INPH.
Methods
This was a retrospective case-control study. From a con-
secutive cohort of patients aged >40  years that under-
went evaluation for ventriculomegaly, we included all 
(n  =  14) patients that: (1) were classified as probable 
(n = 9) or possible (n = 5) INPH according to guidelines 
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[10] (2) underwent shunt surgery and (3) were examined 
with MRI including a T2*-sequence preoperatively. The 
included patients were evaluated between January 2008 
and March 2009. Mean Evans index was 0.40 (range 
0.36–0.49). Mean symptom duration was 3.2 years (range 
1–7). All INPH patients had gait disturbance (100  %), 
13 (93  %) had incontinence and six (43  %) a mild cog-
nitive impairment (defined as Mini Mental Examina-
tion score of 22–26). Cognitive status and number of 
vascular risk factors were not exclusion criteria for the 
INPH-patients as they were for the controls. All patients 
were treated with a ventriculo-peritoneal shunt. Post-
operative improvement was defined as reduced need of 
walking aids and/or walking speed increased by >15  %, 
assessed by comparison of pre-operative and post-
operative standardized exams of gait and walking speed 
performed by experienced physiotherapists at our neu-
rology ward. The mean delay between surgery and post-
operative assessment was 17 weeks (range 13–24 weeks). 
Post-operative follow-up was available in 13 patients. Of 
these 13 patients, ten (77 %) improved, one (8 %) did not 
improve despite that the shunt was patent. Two (15  %) 
patients died from perioperative complications within 
one month of the surgery.
Forty-one healthy controls (HeCo), who considered 
themselves healthy, were recruited between September 
2007 and August 2008 through an advertisement in the 
local newspaper. HeCo were eligible if they did not have 
any psychiatric or neurologic disorder or signs of mani-
fest atherosclerotic disease (such as stroke or myocardial 
infarction). Mini-mental state estimation ≥28 points 
was required, without any contraindication for MRI 
examination. Not more than two vascular risk factors 
out of smoking, hypertension and hyperlipidemia were 
accepted, potential controls with three vascular risk fac-
tors were not enrolled in the study.
All subjects (patients and HeCo) were examined with 
MRI using a hydrocephalus protocol with a Philips 
Achieva 3 Tesla machine and an 8-channel head coil. 
Beside standard T1, T2 and FLAIR sequences, the CMB 
were assessed using a T2*-weighted sequence (axial T2 
FFE, 5  mm slice thickness and 1  mm intersection gap 
(FOV  =  230  ×  230  mm, matrix acquisition 512x512, 
TE/TR = 833 ms/16 ms). The occurrences of CMB were 
independently evaluated by two senior neuroradiologists 
(NB, RB) using the T2* images. The other MRI data were 
used to rule out CMB-mimics and disagreements were 
resolved by consensus decision. The number of micro-
bleeds was assessed using the Microbleed Anatomic Rat-
ing Scale (MARS) [11].
CMB were analyzed using median, intra-quartile range 
(IQR). Mann–Whitney test was used to compared INPH 
and controls. Cohen’s Kappa values were calculated for 
inter-observer agreements. Where appropriate, we used 
95 % CI, χ2-2-test and t test. A p value of <0.05 was pre-
selected as the threshold for statistical significance. IBM 
SPSS v20.0 software was used for all statistical analyses.
The study was approved by the regional ethical review 
board at Umeå University.
Results
This study included 55 subjects; 41 healthy controls and 
14 INPH patients. See Table 1 for baseline comparisons. 
Altogether, 249 CMBs were observed in all subjects. 
Among patients with INPH, the median number of CMB 
was 0.5 (IQR 0–8), and among HeCo the median number 
of CMB was 0 (IQR 0–1; p = 0.035). When only subjects 
with CMB were taken into account, the median number 
CMB was eight (IQR 2–34) in INPH and one (IQR 1–2) 
among the controls (p = 0.005).
The frequency of ≥2 CMB was 43 % in INPH and 10 % 
in HeCo (Table 2; p =  0.01). However, frequency of ≥1 
CMB did not differ between the two groups significantly, 
as it was 50 and 29  % in the INPH group and control 
group, respectively (p = 0.20). The distribution of CMB is 
presented in Table 3.
A concerning finding was that the two INPH patients 
that died within 30 days of shunt placement surgery were 
the two patients with the highest number of CMB (34 
and 174 CMB) in the study. The patient with 174 CMB 
suffered an intracerebral hemorrhage and the other 
Table 1 Baseline comparison between  patients with  idi-
opathic normal pressure hydrocephalus and  healthy con-
trols
INPH idiopathic normal pressure hydrocephalus, MI myocardial infarction, MMT 
mini mental test, SD standard deviation
* 2-sided t-test
a 2-sided χ2-test
b Defined as either blood pressure > 140/90 or current use of blood pressure 
lowering medication






Age mean (SD) 76.4 (5.1) 70.5 (5.4) 0.001*
Women n (%) 6 (43) 18 (44) 1.0a
Previous MI n (%) 0 (0) 0 (0) NA
Previous stroke n (%) 0 (0) 0 (0) NA
Current smoking n (%) 0 (0) 2 (5) 1.0a
Hypertensionb n (%) 12 (86) 28 (68) 0.30a
Treated hyperlipidemia n (%) 0 (0) 6 (15) 0.18a
0–2 risk factorsc 14 (100) 41 (100) NA
3 risk factorsc 0 (0) 0 (0)
Anti-platelet or anti-coagu-
lant medication
4 (29) 0 (0) 0.003a
MMT mean (range) 26.6 (22–30) 29.3 (28–30) 0.002*
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patient had a sepsis with intrathecal bacteremia. Agree-
ment between the observers for the presence of ≥2 CMB 
was 96  % (53/55) with a kappa value of 0.89 (95  %  CI 
0.73–1.0), agreement between the observers for the pres-
ence/absence of any CMB was 98 % (54/55) with a kappa 
value of 0.96 (95 % CI 0.88–1.0).
Discussion
This was a preliminary study, which revealed that the 
prevalence of CMBs was higher in patients with INPH 
than in healthy controls. Two serious adverse events 
occurred after shunt surgery, and these two patients 
had extensive CMB. There is no obvious causative link 
between CMB and the features of INPH such as large 
ventricles and periventricular edema [10]. The associa-
tion is likely due to the fact that both CMB and INPH are 
associated with small vessel disease and vascular risk fac-
tors [4–7, 12]. Hence CMB are more common in patients 
with INPH. A similar association with vascular disease 
has also been proposed for CMB and dementia [9], and 
for CMB and increased risk of cerebral hemorrhage in 
patients treated with intravenous thrombolysis [13].
Our estimation of the prevalence of any CMB (50  %) 
was similar to that of patients with ischemic stroke 
(49  %) and other vascular disorders such as vascu-
lar dementia (59  %) and vascular Parkinsonism (56  %); 
whereas similar non-vascular degenerative disorders 
have lower prevalence: Non-vascular dementia 21 % and 
idiopathic Parkinsons disease 18 % [9, 14, 15]. Thus, our 
findings contribute to a better understanding of the eti-
ology of INPH and support the suggested association 
between INPH, small vessel disease and vascular risk 
factors [6, 7]. Combined, these findings suggest that 
INPH is a combination of vascular disease and cerebro-
spinal fluid dynamic disorder. However, more detailed 
studies of the association between INPH and vascular 
risk factors are warranted. The two patients with the 
highest number of CMB died within 30 days after shunt 
placement. One of the causes of death (intracerebral 
hematoma) could reasonably be associated with CMB. It 
is well known that intracerebral hemorrhage can occur 
after severe complication to shunt placement [16]. As 
this is a small study, this might very well be a chance 
finding.
We used ≥2 CMB as outcome in this study. We did 
not use the presence of any (≥1) CMB as outcome as it 
is reasonable to argue that one CMB can be considered 
a normal variant rather than pathological: Although no 
CMB is most common among the elderly (85  %), the 
presence of any one CMB is also common (9 %); whereas 
only 6 % has ≥2 CMB [5, 6]. Also, ≥2 CMB is required 
to cause a clinical effect in diseases [13, 17]. A consid-
erable weakness of this study is the small sample size. 
Another weakness of the study was that the mean age 
of the INPH patients was higher than for HeCo because 
the controls were not recruited to match specific INPH 
patients. Since CMB prevalence increases with age, a part 
of the difference in CMB prevalence might have been 
caused by difference in age. However, in support of this 
study,agreement between the reviewers (kappa 0.89) was 
in the upper tier compared to previous studies using T2* 
(kappa 0.33–0.88) [4].
Conclusion
Almost half of patients with INPH have several (≥2) 
CMB and several CMB seems to be more common 
among patients with INPH than among controls. If these 
preliminary data can be confirmed, it would support the 
hypothesis that INPH pathophysiology includes a vascu-
lar component.
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Table 2 Number of participants with cerebral microbleeds 
among idiopathic normal pressure hydrocephalus patients 
and healthy controls
INPH Healthy controls
Number of subjects 14 41
0 CMB n (%) 7 (50) 29 (71)
1 CMB n (%) 1 (7) 8 (20)
≥2 CMB n (%) 6 (43) 4 (10)
≥5 CMB n (%) 4 (29) 0 (0)
Table 3 Location of  the cerebral microbleeds among  the 
patients with  idiopathic normal pressure hydrocephalus 
and healthy controls
INPH Healthy controls
Number of subjects with a CMB 7 12
Infratentorial, n (%) 4 (57) 2 (17)
Subcortical (“deep”), n (%) 5 (71) 6 (50)
Lobar, n (%) 4 (57) 4 (57)
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